Locations:

Tag: hepatocellular carcinoma

22-DDI-2730958-Salivary-Biomarkers-identifying-Liver-Cancer-pilot-study-650×450-1

March 14, 2022/Basic & Translational Science

Salivary miRNAs Show Potential as Noninvasive Biomarkers of Hepatocellular Carcinoma

Novel study uses machine learning to create accurate predictive model for detection

October 8, 2020/Cancer/Tumor Oncology

FDA Approves New Treatment Regime for Advanced Liver Cancer

IMbrave-150 changes standard of care

February 28, 2020/Cancer/Radiation Oncology

Case Report: Combination Radiotherapy for Mixed Liver Tumor

Treating a challenging cancer with novel use of radioembolization and SBRT

October 28, 2019/Cancer

Statins Reduce Risk of Hepatocellular Carcinoma

Study finds a 43% lower risk of HCC in statin users

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

TNF alpha with infliximab fab fragment from NCBI

May 20, 2019/Digestive/Research

Anti-TNF Therapy Increases Infection Risk in Patients with Comorbid Inflammatory Conditions and Cirrhosis

Study results highlight need for surveillance, education

April 25, 2018/Digestive/Research

Pretransplant Locoregional Therapy for Advanced HCC May Optimize Long-Term Survival

Response to locoregional therapy helps predict tumor behavior and transplant success

October 18, 2017/Digestive/Innovation

Cleveland Clinic Researchers Develop New Criteria for Assessing Liver Cancer Patients for Transplantation

Model is the first continuous risk score for liver cancer

August 16, 2017/Cancer

Complex Liver Resection As a Curative Surgery for HCC: A Case Study

Skilled team provides advanced surgical interventions

BackPage 1 of 1Next